Purdue Pharma L.P. et al v. Sandoz Inc. > Summary
Court Case Number 1:12-cv-05082
Filing Date Jun 28, 2012
Court New York Southern District Court
Status Unknown
Defendant
Plaintiff Attorneys
8Purdue Pharma
Attorney Name: Sona De
Ropes & Gray LLP
Purdue Pharma
Attorney Name: Robert J. Goldman
Ropes & Gray LLP
Purdue Pharma
Attorney Name: Pablo Daniel Hendler
Ropes & Gray LLP
Grunenthal
Attorney Name: Stephen D. Hoffman
Wilk Auslander
Grunenthal
Attorney Name: Basil J. Lewris
Finnegan, Henderson, Farabow, Garrett & Dunner
Grunenthal
Attorney Name: Joann Marie Neth
Finnegan, Henderson, Farabow, Garrett & Dunner
Grunenthal
Attorney Name: Jennifer H. Roscetti
Finnegan, Henderson, Farabow, Garrett & Dunner
Grunenthal
Attorney Name: Anthony C. Tridico
Finnegan, Henderson, Farabow, Garrett & Dunner
Defendant Attorneys
Sandoz
Attorney Name: Christopher J. Glancy
White & Case
Counter Defendant
8Purdue Pharma
Attorney Name: Sona De
Ropes & Gray LLP
Purdue Pharma
Attorney Name: Robert J. Goldman
Ropes & Gray LLP
Purdue Pharma
Attorney Name: Pablo Daniel Hendler
Ropes & Gray LLP
Grunenthal
Attorney Name: Stephen D. Hoffman
Wilk Auslander
Grunenthal
Attorney Name: Basil J. Lewris
Finnegan, Henderson, Farabow, Garrett & Dunner
Grunenthal
Attorney Name: Joann Marie Neth
Finnegan, Henderson, Farabow, Garrett & Dunner
Grunenthal
Attorney Name: Jennifer H. Roscetti
Finnegan, Henderson, Farabow, Garrett & Dunner
Grunenthal
Attorney Name: Anthony C. Tridico
Finnegan, Henderson, Farabow, Garrett & Dunner
Counter Claimant
Sandoz
Attorney Name: Christopher J. Glancy
White & Case
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
08114383 | Abuse-proofed dosage form | Feb 14, 2012 |
07683072 | Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone | Mar 23, 2010 |
07674799 | Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone | Mar 9, 2010 |
07674800 | Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone | Mar 9, 2010 |
06488963 | Hot-melt extrudable pharmaceutical formulation | Dec 3, 2002 |